Bio Protech Inc.

A199290

KR7199290008

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 23:00:00 22/05/2024 BST			5-day change	1st Jan Change
747 ^KRW	0.00%		-6.27%	-17.91%

2023	Bio Protech Inc. announced that it has received KRW 2.299996268 billion in funding from Korea Investment & Securities Co., Ltd., Nine Tree Investment Co., Ltd.	CI
2023	Bio Protech Inc. announced that it expects to receive KRW 2.299996268 billion in funding from Korea Investment & Securities Co., Ltd., Nine Tree Investment Co., Ltd.	CI

Bio Protech Inc. announced that it has received KRW 1 billion in funding

August 04, 2019

On August 5, 2019, Bio Protech Inc. (XKON:A199290) closed the transaction. The company has issued series 5 unregistered unsecured unguaranteed private convertible bonds in the transaction.

Latest news about Bio Protech Inc.

Bio Protech Inc. announced that it has received KRW 2.299996268 billion in funding from Korea Investment & Securities Co., Ltd., Nine Tree Investment Co., Ltd.	02/05/23	CI
Bio Protech Inc. announced that it expects to receive KRW 2.299996268 billion in funding from Korea Investment & Securities Co., Ltd., Nine Tree Investment Co., Ltd.	17/04/23	CI
Bio Protech Inc. announced that it expects to receive KRW 499.9995 million in funding	24/11/22	CI
Bio Protech Inc. announced that it has received KRW 500 million in funding	09/02/22	CI
Bio Protech Inc. announced that it expects to receive KRW 500 million in funding	08/02/22	CI
Bio Protech Inc. announced that it has received KRW 289.998 million in funding from Mijin Company Co., Ltd.	23/01/22	CI
Bio Protech Inc. announced that it has received KRW 169.48125 million in funding	29/12/21	CI
Bio Protech Inc. cancelled the transaction announced on December 9, 2021	27/12/21	CI
Bio Protech Inc. cancelled the transaction announced on December 2, 2021	27/12/21	CI
Bio Protech Inc. announced a financing transaction	08/12/21	CI
Bio Protech Inc. announced that it expects to receive KRW 500 million in funding from Mijin Company Co., Ltd.	07/12/21	CI
Bio Protech Inc. announced that it expects to receive KRW 169.48125 million in funding	01/12/21	CI
Bio Protech Inc. announced that it expects to receive KRW 1.4999985 billion in funding from Mijin Company Co., Ltd, and other investors	01/12/21	CI
Bio Protech Inc. announced that it has received KRW 150 million in funding from T Investment, Mijin Company Co., Ltd.	08/07/21	CI
Bio Protech Inc. announced that it expects to receive KRW 150 million in funding from T Investment, Mijin Company Co., Ltd.	07/07/21	CI
Bio Protech Inc. announced that it has received KRW 2 billion in funding	15/04/21	CI
Bio Protech Inc. announced that it expects to receive KRW 2 billion in funding	08/04/21	CI
Bio Protech Inc. announced that it has received KRW 540 million in funding	05/04/21	CI
Bio Protech Inc. announced that it has received KRW 2 billion in funding	17/03/21	CI
Bio Protech Inc. announced that it has received KRW 500 million in funding	13/02/20	CI
Bio Protech Inc. announced that it has received KRW 1 billion in funding	04/08/19	CI
Bio Protech Inc. announced that it expects to receive KRW 1 billion in funding	01/08/19	CI
Bio Protech Inc. announced that it has received KRW 3 billion in funding	10/07/19	CI
Bio Protech Inc. announced that it expects to receive KRW 3 billion in funding	08/07/19	CI
Nau Ib Capital, C Squared Asset Management Co., Ltd. and Yangtze River Delta Venture Capital Fund, a fund managed by DT Capital Partners and Delta Venture Capital Investment Management Company acquired 11.94% stake in Bio Protech Inc. (XKON : A199290) from KoFC-Neoplux Pioneer Champ 2010-7, a fund managed by Neoplux Co., Ltd. for KRW 1 billion.	20/05/19	CI

BIO PROTECH INC. is a Korea-based company mainly engaged in manufacture of medical equipment. The Company's products mainly consist of electrocardiogram electrodes, which are used for electrocardiogram tests, electrosurgery plates, electrosurgery pencils and transcutaneous electrical nerve stimulators (TENS) electrodes, which are used for providing conductive interface between the TENS generator and the patientâs skin.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
BIO PROTECH INC.	-17.91%	7.91M
SARTORIUS AG	-21.31%	17.75B
QUIDELORTHO CORPORATION	-42.99%	2.85B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.67%	1.92B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-7.25%	1.58B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-18.78%	952M
CONTEC MEDICAL SYSTEMS CO.,LTD	-24.92%	888M
REVENIO GROUP OYJ	+4.64%	828M
VAREX IMAGING CORPORATION	-27.98%	611M
CELLAVISION AB	+19.10%	591M

Medical Diagnostic & Testing Equipment

Bio Protech Inc.

Equities

A199290

KR7199290008

Advanced Medical Equipment & Technology

Bio Protech Inc. announced that it has received KRW 1 billion in funding

Latest news about Bio Protech Inc.

Chart Bio Protech Inc.

Company Profile

Sector Medical Diagnostic & Testing Equipment